Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
It is well-known for its regenerative and healing qualities
Retatrutide is an investigational triple-hormone receptor agonist developed by Eli Lilly that targets three receptors: GIP (glucose-dependent insulinotropic polypeptide), GLP-1 (glucagon-like peptide-1), and glucagon
Fast turnover suggests purging
Research Applications: Investigated in tissue and cellular repair models Studied in peptide-mediated signaling pathways Explored in regenerative research environments Product Details: 5mg / 10mg per vial 99% purity Lyophilized powder For details on designation see our Research Use Only policy
US$ 21.50
US$ 22.65
US$ 23.15
US$ 25.10
US$ 29.13
US$ 29.29
